Two cases of partial dominant interferon-γ receptor 1 deficiency that presented with different clinical courses of bacille Calmette-Guérin multiple osteomyelitis

Journal of Infection and Chemotherapy

Volumn 19, Issue 4, 2013, Pages 757-760

  Obinata, Kaoru ^a,b   Lee, Tsubasa ^a   Niizuma, Takahiro ^a   Kinoshita, Keiji ^a   Shimizu, Toshiaki ^c   Hoshina, Takayuki ^d   Sasaki, Yuka ^d   Hara, Toshiro ^d  

^a Department of Surgery Koshigaya Municipal Hospital   (Japan)

^b JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Bacille Calmette Gu rin; Interferon receptor 1 deficiency; Levofloxacin; Multiple osteomyelitis; Mycobacterial infection

Indexed keywords

BCG VACCINE; CLARITHROMYCIN; ETHAMBUTOL; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; ISONIAZID; LEVOFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ARTICLE; BONE BIOPSY; BONE RADIOGRAPHY; BONE SCINTISCANNING; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHILD; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEMUR; FOLLOW UP; FRAMESHIFT MUTATION; GRANULOMA; GRANULOMATOUS INFLAMMATION; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC SCAR; IMMUNE DEFICIENCY; JAPANESE; KELOID; LIMB PAIN; LYMPHADENITIS; MALE; MYCOBACTERIUM BOVIS; NECK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PARTIAL DOMINANT INTERFERON GAMMA RECEPTOR 1 DEFICIENCY; PRESCHOOL CHILD; RELAPSE; REMISSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RIB; SCHOOL CHILD; SEQUENCE ANALYSIS; SKIN ABSCESS; SKULL; TUBERCULIN TEST; TUBERCULOSIS; VERTEBRA;

ANTITUBERCULAR AGENTS; BCG VACCINE; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MYCOBACTERIUM BOVIS; OSTEOMYELITIS; RECEPTORS, INTERFERON; TUBERCULOSIS; VIRUS DISEASES;

EID: 84882255787     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0493-5     Document Type: Article

References (10)

1. Dupuis S, Döffinger R, Picard C, Fieschi C, Altare F, Jouanguy E, et al. Human interferon-γ-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev. 2000;178:129-37.
2. Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol. 2006;18:347-61.
3. Sasaki Y, Nomura A, Kusuhara K, Takada H, Ahmed S, Obinata K, et al. Genetic basis of patients with Bacille Calmette-Guérin (BCG) osteomyelitis in Japan: identification of dominant partial interferon-γ receptor 1 deficiency as a predominant type. J Infect Dis. 2002;185:706-9.
4. Milstein JB, Gibson JJ. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine efficacy and safety. Bull WHO. 1990;68:93-108.
5. Toida I, Nakata S. Severe adverse reactions after vaccination with Japanese BCG vaccine: a review. Kekkaku. 2007;82:809-24 (in Japanese).
6. Hoshina T, Takada H, Sasaki-Mihara Y, Kusuhara K, Ohshima K, Okada S, Kobayashi M, Ohara O, Hara T. Clinical and host genetic characteristics of Mendelian susceptibility to mycobacterial disease in Japan. J Clin Immunol. 2011;31:309-14.
7. Lee W-I, Huang J-L, Lin T-Y, Hsueh C, Wong AM, Hsieh M-Y, et al. Chinese patients with defective IL-12/23-interferon-γ circuit in Taiwan: partial dominant interferon-γ receptor 1 mutation presenting as cutaneous granuloma and IL-12 receptor γ1 mutation as pneumatocele. J Clin Immunol. 2009;29:238-45.
8. Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Barreto R, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet. 2004;364:2113-21.
9. Remus N, Reichenbach J, Picard C, Rietschel C, Wood P, Lammas D, et al. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood. Pediatr Res. 2001;50:8-13.
10. Fennelly GJ. Mycobacterium bovis versus Mycobacterium tuberculosis as a cause of acute cervical lymphadenitis without pulmonary diseases. Pediatr Infect Dis J. 2004;23:590-1.